2017%2011:48:07%20AM

Mission Statement

  • To develop a nationally and internationally recognized center of excellence in cardiovascular research and medicine.

  • To facilitate the training of young scientists, including postdoctoral fellows, graduate students, medical students and residents in cardiovascular research and medicine.

  • To encourage the development of basic science, translational, and clinical research with funding from federal agencies and industry.

 


News and Events

 

Please join us in congratulating the LSUHSC Cardiovascular Center of Excellence’s own David Polhemus, Ph.D. for receiving the Chancellor’s Award at the Graduate Research Day Award Ceremony this past Friday, November 3, 2017. The award is given to each year to “a high ranking graduating student who has done the most to promote the health sciences and the School before the public. Selection is made by a committee of the faculty appointed by the Dean, with consultation by members of the graduating class.

 

2017%208:22:59%20AM 2017%208:23:24%20AM

 

Congratulations, David!

 


2017%2010:25:14%20AM

Cardiovascular Center at the 2017 LSU Medical School Alumni Gala

 


 

Dr. Danielle Gottlieb Sen Nominated for New Orleans CityBusiness
2017 Women of the Year Award

2017%203:53:44%20PM

Dr. Danielle Gottlieb Sen, M.D., M.S., MPH, of the Cardiovascular Center of Excellence and New Orleans Children's Hospital has been nominated by her peers as one of the Top 50 New Orleans' Woman of 2017 by New Orleans CityBusiness. Dr. Gottlieb Sen is both a Pediatric Cardiovascular Surgeon and Assistant Professor for the Department of Surgery. Additonally, her contribution to the Cardiovascular field has led to numerous advancements in Cardiovascular care for infants, childrens and adults. She is currently 1 out of approximately 15 female pediatric cardiovascular surgeons in North America.

"The 19th annual “Women of the Year” will be recognized at a noon luncheon Thursday, Nov. 2 at the Hyatt Regency, when an overall Woman of the Year will be announced. A special insert spotlighting all “Women of the Year” honorees will run in the Nov. 10 issue of CityBusiness." (via New Orleans City Buisness)

To view all the nominees for this prestigous award, click here New Orleans CityBusiness.

 


Cardiovascular Center Published in Journal of the American College of Cardiology

2017%2010:05:11%20AM

 

The Cardiovascular Center of Excellence, along with the Department of Pharmacology and Experimental Therapeutics, led an all LSU Health New Orleans original investigation into understanding, "Renal Sympathetic Denervation Protects the Failing Heart Via Inhibition of Neprilysin Activity in the Kidney." The investigation was led by CV Center members David Polhemus, Ph.D., Rishi Trivedi, Ph.D., Zhen Li and Amy Scarborough.

The study had a clear objective that 'investigated the effects of radiofrequency renal nerve denervation (RF-RDN) on the pathobiology of HF and the interaction between the renal sympathetic nerves and natriuretic peptide (NP) metabolism.'

 

Full Investigation here.

Full Editorial here.

 


Presenting the 2018 Seminar Series

 

The LSUHSC Center of Excellence in Cardiovascular Research hosts an exciting Cardiovascular Biology Seminar Series! Renowned scientists from prestigious and innovative institutions visit our Center regularly, sharing ideas and inspiring us to become the best. Please take a moment to view the LSU Health Science Center Medical School – Seminar Calendar. These seminars are golden opportunities to learn and visit with other scientists who aspire with similar interests.

To see the full list of presenters, click here.

Downloadable 2018 Seminar Series Poster, (PDF) 

 


2017%208:51:45%20AM

LSUHSC Cardiovascular Center and Novo Biosciences Receive
$1.5 million NIH Grant to Study Myocardial Regeneration

 

New Orleans, LA (August 28, 2017) – LSU Health Cardiovascular Center of Excellence received a grant award from the National Heart, Lung and Blood Institute to research the development, a novel agent, MSI-1346, for therapeutic stimulation of heart regeneration following acute myocardial infarction and heart failure. The grant will provide more than $500,000 in funding over two years to LSUHSC-New Orleans along with Novo Biosciences in Bar Harbor, Maine in ongoing research for the project.

 

To read the full press release, click here.


$1.3 Million Grant to Fund Research on Reducing Cardiac Injury
with the First Drug-Eluting Guidewire

 

New Orleans, LA (August 11, 2017) – Adenopaint, LLC of Atlanta, GA, in conjunction with LSU Health New Orleans Cardiovascular Center of Excellence, has been awarded an SBIR Phase II grant in the amount of $1.3 million over two years by the National Heart, Lung and Blood Institute.

The funding will be used to study the company’s Adenowire, a novel guidewire coated with a drug which is released during percutaneous coronary intervention (PCI) to prevent and reverse vascular and cardiac tissue injury during PCI and therefore improve outcomes in cardiovascular diseases.

 

To read the full press release, click here.


$3.7 Million Grant to Fund Research on Novel Drug Targeting Heart Diseases

2017%209:34:38%20AM

 

New Orleans, LA (August 11, 2017) – The Exscien Corporation of Louisville, KY, in conjunction with LSU Health New Orleans Cardiovascular Center of Excellence, has been awarded an SBIR Fast-Track grant in the amount of $3.7 million over three years by the National Heart, Lung and Blood Institute. The funding will be used to study the company’s first in a new class of drugs that repairs DNA damage to reduce cardiac tissue injury and improve outcomes in cardiovascular diseases.

 

To read the full press release, click here.


Cardiovascular Center Welcomes, Thomas E. Sharp III, Ph.D.

2017%201:58:41%20PM

Dr. Thomas E. Sharp III joined the Cardiovascular Center of Excellence in July as a Postdoctoral Researcher. Dr. Sharp joins us from Temple University, Lewis Katz School of Medicine where he recieved his Ph.D. while working under renowned professor, John Elrod, Ph.D.. He will work alongside both Dr. Lefer and Dr. Goodchild to continue ongoing research.


Click here for more News and Events